Attorneys for Luigi Mangione, accused of killing United Healthcare CEO Brian Thompson, meet federal prosecutors on Friday amid rumours of a possible plea agreement.
Mangione faces two federal stalking‑to‑death charges, each carrying an unlimited life sentence. It is unclear which particular charge a plea might address.
"A conference is scheduled for 11 a.m. on Friday," stated Jamie McDonald, the U.S. Attorney for the Southern District of New York. The meeting’s purpose is to discuss terms that might avoid a trial.
The defendant also faces a separate New York state trial over the same homicide. He maintains a not‑guilty plea in both courts.
A plea deal does not guarantee acceptance; it must first be approved by the court, and a new plea hearing is normally set thereafter.
Federal prosecutors argue Mangione travelled between states and used electronic surveillance with intent to kill or harm Thompson—actions that allegedly led to his death. They also cited it as the basis for the stalking charges.
In January, a federal judge dismissed a murder‑by‑firearm charge that could have carried the death penalty.
The lawyers for Mangione have previously argued that the state and federal cases should not coexist, citing treble‑plea concerns. Though the courts have allowed the trials to proceed, a federal guilty plea could trigger New York double‑jeopardy limits, potentially influencing the state case.
If a federal prosecution is deemed complete, the state should not pursue the same facts, according to Mitchell Epner, a white‑collar attorney. The exact effect on the state trial remains uncertain and will likely be addressed by the presiding judge.
State trial is set for 8 September; federal trial is scheduled for January 2027. Outcomes in the federal case could alter the strategy for the state audience and the overall legal trajectory of the case.
